KPC Pharmaceuticals Inc Financial Flexibility Index
KPC Pharmaceuticals Inc financial flexibility index. KPC Pharmaceuticals Inc (600422) has a Financial Flexibility Index of 0.03x as of December 2025. Free cash flow of CN¥145.61 Million (operating CF CN¥113.07 Million minus capex CN¥32.53 Million) represents 0% of total liabilities (CN¥4.83 Billion). See KPC Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of KPC Pharmaceuticals Inc (1999–2025)
Financial flexibility index of KPC Pharmaceuticals Inc from 1999 to 2025. Historical Financial Flexibility Index trend for KPC Pharmaceuticals Inc across 27 annual periods. Check cash flow quality index of KPC Pharmaceuticals Inc to evaluate the quality of earnings relative to operating cash generation.
KPC Pharmaceuticals Inc Financial Flexibility Index by Year (1999–2025)
KPC Pharmaceuticals Inc financial flexibility index by year from 1999 to 2025. Year-by-year free cash flow to debt coverage for KPC Pharmaceuticals Inc. For the full cash flow conversion analysis, see KPC Pharmaceuticals Inc cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.08x | CN¥379.80 Million | CN¥289.24 Million | CN¥4.83 Billion | ▼ -48.1% |
| 2024 | 0.15x | CN¥887.50 Million | CN¥808.07 Million | CN¥5.87 Billion | ▼ -24.0% |
| 2023 | 0.20x | CN¥863.97 Million | CN¥754.33 Million | CN¥4.34 Billion | ▲ +140.1% |
| 2022 | 0.08x | CN¥355.64 Million | CN¥253.90 Million | CN¥4.29 Billion | ▼ -32.8% |
| 2021 | 0.12x | CN¥487.80 Million | CN¥251.63 Million | CN¥3.95 Billion | ▼ -23.6% |
| 2020 | 0.16x | CN¥568.67 Million | CN¥409.94 Million | CN¥3.52 Billion | ▼ -35.5% |
| 2019 | 0.25x | CN¥776.85 Million | CN¥429.50 Million | CN¥3.10 Billion | ▲ +29.5% |
| 2018 | 0.19x | CN¥569.33 Million | CN¥352.07 Million | CN¥2.94 Billion | ▼ -3.0% |
| 2017 | 0.20x | CN¥511.27 Million | CN¥242.53 Million | CN¥2.56 Billion | ▼ -30.6% |
| 2016 | 0.29x | CN¥514.61 Million | CN¥311.16 Million | CN¥1.79 Billion | ▼ -32.6% |
| 2015 | 0.43x | CN¥687.43 Million | CN¥476.62 Million | CN¥1.61 Billion | ▼ -31.0% |
| 2014 | 0.62x | CN¥602.11 Million | CN¥379.13 Million | CN¥974.40 Million | ▲ +36.8% |
| 2013 | 0.45x | CN¥454.62 Million | CN¥241.97 Million | CN¥1.01 Billion | ▲ +46.9% |
| 2012 | 0.31x | CN¥336.55 Million | CN¥213.33 Million | CN¥1.10 Billion | ▲ +19.6% |
| 2011 | 0.26x | CN¥183.09 Million | CN¥140.24 Million | CN¥712.37 Million | ▼ -1.2% |
| 2010 | 0.26x | CN¥154.98 Million | CN¥90.82 Million | CN¥595.84 Million | ▼ -10.7% |
| 2009 | 0.29x | CN¥147.39 Million | CN¥128.57 Million | CN¥505.79 Million | ▲ +35.4% |
| 2008 | 0.22x | CN¥104.68 Million | CN¥91.59 Million | CN¥486.48 Million | ▼ -18.6% |
| 2007 | 0.26x | CN¥146.72 Million | CN¥130.06 Million | CN¥554.98 Million | ▲ +59.4% |
| 2006 | 0.17x | CN¥90.28 Million | CN¥61.25 Million | CN¥544.44 Million | ▲ +193.6% |
| 2005 | -0.18x | CN¥-115.25 Million | CN¥-174.52 Million | CN¥650.31 Million | ▼ -323.4% |
| 2004 | 0.08x | CN¥35.60 Million | CN¥-2.78 Million | CN¥448.75 Million | ▼ -75.6% |
| 2003 | 0.33x | CN¥93.32 Million | CN¥61.23 Million | CN¥286.76 Million | ▼ -35.5% |
| 2002 | 0.50x | CN¥97.00 Million | CN¥17.38 Million | CN¥192.11 Million | ▲ +21.0% |
| 2001 | 0.42x | CN¥85.20 Million | CN¥67.07 Million | CN¥204.24 Million | ▲ +39.8% |
| 2000 | 0.30x | CN¥71.96 Million | CN¥47.76 Million | CN¥241.15 Million | ▲ +20.4% |
| 1999 | 0.25x | CN¥72.90 Million | CN¥60.24 Million | CN¥294.19 Million | — |